- Home
- NAII vs BCLI Comparison
NAII vs BCLI Comparison
Compare NAII & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAII
- BCLI
- Stock Information
- Founded
- NAII 1980
- BCLI 2000
- Country
- NAII United States
- BCLI United States
- Employees
- NAII N/A
- BCLI N/A
- Industry
- NAII Medicinal Chemicals and Botanical Products
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NAII Health Care
- BCLI Health Care
- Exchange
- NAII Nasdaq
- BCLI Nasdaq
- Market Cap
- NAII 28.0M
- BCLI 25.0M
- IPO Year
- NAII 1987
- BCLI N/A
- Fundamental
- Price
- NAII $4.42
- BCLI $2.12
- Analyst Decision
- NAII
- BCLI Strong Buy
- Analyst Count
- NAII 0
- BCLI 1
- Target Price
- NAII N/A
- BCLI $30.00
- AVG Volume (30 Days)
- NAII 18.2K
- BCLI 86.5K
- Earning Date
- NAII 11-07-2024
- BCLI 11-12-2024
- Dividend Yield
- NAII N/A
- BCLI N/A
- EPS Growth
- NAII N/A
- BCLI N/A
- EPS
- NAII N/A
- BCLI N/A
- Revenue
- NAII $113,796,000.00
- BCLI N/A
- Revenue This Year
- NAII N/A
- BCLI N/A
- Revenue Next Year
- NAII N/A
- BCLI N/A
- P/E Ratio
- NAII N/A
- BCLI N/A
- Revenue Growth
- NAII N/A
- BCLI N/A
- 52 Week Low
- NAII $4.13
- BCLI $1.95
- 52 Week High
- NAII $7.37
- BCLI $11.85
- Technical
- Relative Strength Index (RSI)
- NAII 35.54
- BCLI 31.68
- Support Level
- NAII $4.22
- BCLI $1.97
- Resistance Level
- NAII $4.62
- BCLI $2.68
- Average True Range (ATR)
- NAII 0.30
- BCLI 0.29
- MACD
- NAII -0.02
- BCLI 0.05
- Stochastic Oscillator
- NAII 30.23
- BCLI 21.62
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.